Skip to main content
. 2019 Aug 22;8(9):954. doi: 10.3390/cells8090954

Table 3.

Survival analysis by a Cox regression.

Positive Association Negative Association
Cohort Cox Coefficient p-Value Cohort Cox Coefficient p-Value
DYSF EXPRESSION
CESC 0.266 4.20e−02 SARC −0.277 1.00e−02
STAD 0.171 4.80e−02 KIRC −0.220 1.00e−02
OTOF EXPRESSION
KIRC 0.377 1.50e 06 BLCA −0.275 4.50e−04
KIRP 0.413 4.90e−03 SKCM −0.169 1.40e−02
MYOF EXPRESSION
LGG 0.441 1.40e 05 SKCM −0.163 1.90e−02
PAAD 0.561 1.70e 05
LAML 0.215 4.70e−02
FER1L4 EXPRESSION
KIRC 0.356 5.20e 06 BLCA −0.383 2.90e 06
KIRP 0.492 1.10e−03 SKCM −0.225 1.10e−03
LGG 0.244 4.00e−03
FER1L5 EXPRESSION
LUAD −0.199 1.30e−02
FER1L6 EXPRESSION
KIRC −0.160 4.80e−02
READ −0.401 4.90e−02

Ferlin gene expression from cohorts with cancer was submitted to a survival analysis with a Cox regression. The red rows indicate a negative Cox coefficient, the green rows indicate positive Cox coefficient. The bold p-values were considered as highly significant (p < 10−4). Bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), acute myeloid leukemia (LAML), brain lower grade glioma (LGG), lung adenocarcinoma (LUAD), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), sarcoma (SARC), skin cutaneous melanoma (SKCM), stomach adenocarcinoma (STAD).